A recent study revealed that variant allele of MDM4 3’-UTR polymorphism rs4245739 abrogates the miR-191 target site and results in increased MDM4 expression, which was associated with increased risk for recurrence, accelerated tumor progression, and chemotherapy resistance in ovarian carcinoma [115]. The gene discussed is MDM4; the disease is neoplasm.